Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Qi, Lei ^a   Zhu, Feng ^b   Li, Shu Hai ^a   Si, Li Bo ^a   Hu, Li Kuan ^a   Tian, Hui ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOBLASTOMA BINDING PROTEIN 2; VASCULOTROPIN; CELLULAR RETINOL BINDING PROTEIN; HIF1A PROTEIN, HUMAN; RBP2 PROTEIN, HUMAN; SMALL INTERFERING RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CAPILLARY DENSITY; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER CELL LINE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR VASCULARIZATION; TUMOR VOLUME; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; CANCER STAGING; ENDOTHELIUM CELL; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NON SMALL CELL LUNG CANCER; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; VASCULARIZATION;

ANTIGENS, CD34; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RETINOL-BINDING PROTEINS, CELLULAR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923089143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106032     Document Type: Article

References (57)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, et al. (2007) Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 25: 5506-5518. (Pubitemid 350232227)
3. Vamesu S (2008) Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol 49: 181-188.
4. Vermeulen PB, van Golen KL, Dirix LY (2010) Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer 116: 2748-2754.
5. Tammela T, Enholm B, Alitalo K, Paavonen K (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563. (Pubitemid 40138976)
6. Mac Gabhann F, Popel AS (2008) Systems biology of vascular endothelial growth factors. Microcirculation 15: 715-738.
7. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
8. Semenza GL (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1-3.
9. Grimshaw MJ (2007) Endothelins and hypoxia-inducible factor in cancer. Endocr Relat Cancer 14: 233-244.
10. Cheng JC, Klausen C, Leung PC (2013) Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett 329: 197-206.
11. Crociani O, Zanieri F, Pillozzi S, Lastraioli E, Stefanini M, et al. (2013) hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer. Sci Rep 3: 3308.
12. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, et al. (2007) RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128: 1063-1076. (Pubitemid 46427869)
13. Secombe J, Li L, Carlos L, Eisenman RN (2007) The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21: 537-551. (Pubitemid 46409469)
14. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, et al. (2007) The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128: 889-900. (Pubitemid 46341416)
15. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr (2005) Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 18: 623-635. (Pubitemid 40804799)
16. Sims RJ 3rd, Reinberg D (2006) Histone H3 Lys 4 methylation: caught in a bind? Genes Dev 20: 2779-2786.
17. Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, et al. (2013) Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res 73: 4711-4721.
18. Wang S, Wang Y, Wu H, Hu L (2013) RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer. PLoS One 8: e84735.
19. Bolas G, de Rezende FF, Lorente C, Sanz L, Eble JA, et al. (2014) Inhibitory effects of recombinant RTS-jerdostatin on integrin alpha1beta1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis. Toxicon 79: 45-54.
20. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, et al. (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18: 4691-4697. (Pubitemid 350246672)
21. Jahangiri A, Aghi MK, Carbonell WS (2014) beta1 integrin: Critical path to antiangiogenic therapy resistance and beyond. Cancer Res 74: 3-7.
22. Kim CH, Cho YS, Chun YS, Park JW, Kim MS (2002) Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 90: E25-33.
23. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, et al. (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579. (Pubitemid 34876495)
24. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, et al. (1998) The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 82: 1225-1232. (Pubitemid 28155382)
25. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, et al. (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56: 2671-2676. (Pubitemid 26170706)
26. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, et al. (2005) The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11: 8326-8331. (Pubitemid 41746944)
27. Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, et al. (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46: 31-36. (Pubitemid 40193695)
28. Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, et al. (2013) VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer. PLoS One 8: e53070.
29. Malhotra R, Tyson DW, Rosevear HM, Brosius FC 3rd (2008) Hypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells. BMC Cardiovasc Disord 8: 9.
30. Kim SM, Park JH, Kim KD, Nam D, Shim BS, et al. (2014) Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. Phytother Res 28: 423-431.
31. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH (2007) Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300. (Pubitemid 47395167)
32. Jamison J, Wang JH, Wells A (2014) PKCdelta regulates force signaling during VEGF/CXCL4 induced dissociation of endothelial tubes. PLoS One 9: e93968.
33. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
34. Keith B, Johnson RS, Simon MC (2012) HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22.
35. Dayan F, Mazure NM, Brahimi-Horn MC, Pouyssegur J (2008) A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenviron 1: 53-68.
36. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443. (Pubitemid 44050138)
37. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, et al. (2007) Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 100: 70-78. (Pubitemid 46066775)
38. Zeng J, Ge Z, Wang L, Li Q, Wang N, et al. (2010) The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 138: 981-992.
39. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
40. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.
41. Shijubo N, Kojima H, Nagata M, Ohchi T, Suzuki A, et al. (2003) Tumor angiogenesis of non-small cell lung cancer. Microsc Res Tech 60: 186-198. (Pubitemid 36125707)
42. D'Amico TA (2004) Angiogenesis in non-small cell lung cancer. Semin Thorac Cardiovasc Surg 16: 13-18.
43. Crabb SJ, Patsios D, Sauerbrei E, Ellis PM, Arnold A, et al. (2009) Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer. J Clin Oncol 27: 404-410.
44. Maeda A, Nakata M, Yasuda K, Yukawa T, Saisho S, et al. (2013) Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncol Rep 29: 39-44.
45. Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, et al. (2009) Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 387: 442-448.
46. Rovina N, Hillas G, Dima E, Vlastos F, Loukides S, et al. (2011) VEGF and IL-18 in induced sputum of lung cancer patients. Cytokine 54: 277-281.
47. Charpidou A, Gkiozos I, Konstantinou M, Eleftheraki A, Demertzis P, et al. (2011) Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. Cancer Lett 304: 144-153.
48. Park S, Ha SY, Cho HY, Chung DH, Kim NR, et al. (2011) Prognostic implications of hypoxia-inducible factor-1alpha in epidermal growth factor receptor-negative non-small cell lung cancer. Lung Cancer 72: 100-107.
49. Ha GH, Park JS, Breuer EK (2013) TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett 332: 63-73.
50. Lin JC, Wu YY, Wu JY, Lin TC, Wu CT, et al. (2012) TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol Med 4: 472-485.
51. Lee DY, Li YS, Chang SF, Zhou J, Ho HM, et al. (2010) Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway. J Biol Chem 285: 30-42.
52. Thamilselvan V, Craig DH, Basson MD (2007) FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 21: 1730-1741. (Pubitemid 46855619)
53. Moreno-Layseca P, Streuli CH (2014) Signalling pathways linking integrins with cell cycle progression. Matrix Biol 34: 144-153.
54. Poettler M, Unseld M, Braemswig K, Haitel A, Zielinski CC, et al. (2013) CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior. Mol Cancer 12: 169.
55. Kalhori V, Kemppainen K, Asghar MY, Bergelin N, Jaakkola P, et al. (2013) Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1alpha in Thyroid Follicular Carcinoma Cells. PLoS One 8: e66189.
56. Trisciuoglio D, Gabellini C, Desideri M, Ziparo E, Zupi G, et al. (2010) Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90. PLoS One 5: e11772.
57. Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, et al. (2012) Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1alpha. PLoS One 7: e50394.